Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors ( OCT4, SOX2, NANOG , and LIN28 ) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations (for example, mutation through viral integration) are eliminated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retro/lentiviruses have enabled genetic approaches in cultured primary cells to ectopically express genes of interest (1–6).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Viral screens using focused overexpression libraries can identify putative reprogramming factors, for example, by identifying a defined set of transcription factors that are selectively required to induce pluripotent stem cells (2–4,7) or trans-differentiate from mature somatic cell into another mature somatic cell (1,8–11).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Despite the power of viral technologies, pooled screens for cell reprogramming have generally adopted a one-by-one elimination approach or testing for exhaustive combinations and interrogating phenotypes in cell culture from transgenic mice (1,3,10) and/or aberrantly cloned cell lines (12).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Successful transformation of human somatic cells into iPSCs was first carried out in 2007 using a lentiviral system [95].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [95]
In the citing paper
“It has been shown that NANOG and LIN28 in combination with SOX2 and OCT4 can reprogram human somatic cells into iPS cells 30 by increasing reprogramming efficiency by 76-fold 60 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [30]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationThe ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
Meissner, A., Wernig, M., & Jaenisch, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1335 · Cited by 763
Homologous recombination in human embryonic stem cells
Zwaka, T. P., & Thomson, J. A. (2003) · Nature Biotechnology · doi:10.1038/nbt788 · Cited by 666
Self-citationVodyanik, M. A., Bork, J. A., Thomson, J. A., & Slukvin, I. I. (2005) · Blood · doi:10.1182/blood-2004-04-1649 · Cited by 619
Self-citation
Cited by
Items 901–1,000 of 1,133
Wang, D., Lu, P., Zhang, H., Luo, M., Zhang, X., Wei, X., Gao, J., Zhao, Z., & Liu, C. (2014) · Oncotarget · doi:10.18632/oncotarget.2506 · Cited by 162
“Nanog is a transcription factor, and Nanog and Oct-4 induce the expression of each other [11]: Both proteins play key roles in maintaining the self-renewal capacity and pluripotency of embryonic stem cells and are biomarkers of CSC [9, 12-16].”
BackgroundZhang, Y., Li, W., Laurent, T., & Ding, S. (2012) · Journal of Cell Science · doi:10.1242/jcs.096032 · Cited by 161
“…1998), epiblast stem cells (EpiSCs) derived from the epiblast layer of the implanted embryos (Brons et al., 2007; Tesar et al., 2007), and induced pluripotent stem cells (iPSCs) generated from somatic cells by reprogramming (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007).”
BackgroundInfluentialDirect reprogramming of human astrocytes into neural stem cells and neurons
Corti, S., Nizzardo, M., Simone, C., Falcone, M., Donadoni, C., Salani, S., Rizzo, F., Nardini, M., Riboldi, G., Magri, F., et al. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.040 · Cited by 158
“We observed no formation of typical iPSCs in culture, and the pluripotencymarkers SSEA3, SSEA4, TRA-1–60, and TRA-1–81 were not detectable in the transduced condition, whereas both features increased during establishment of iPSCs from human fibroblasts transduced contemporaneously with four factors (OCT4/SOX2/NANOG/Li…”
MethodInfluentialDuan, L., Bhattacharyya, B. J., Belmadani, A., Pan, L., Miller, R. J., & Kessler, J. A. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-3 · Cited by 159
“or other easily accessible tissues and can then be differentiated into neurons [12,13].”
BackgroundThe Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives
Liu, X., Li, W., Fu, X., & Xu, Y. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00645 · Cited by 164
Matsa, E., Burridge, P. W., Yu, K.-H., Ahrens, J. H., Termglinchan, V., Wu, H., Liu, C., Shukla, P., Sayed, N., Churko, J. M., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.07.006 · Cited by 164
“The advent of human induced pluripotent stem cell (hiPSC) reprogramming technologies (Takahashi et al., 2007; Yu et al., 2007) has not only circumvented ethical issues surrounding the use of human embryonic stem cells (hESCs) but also provided patient-specific cells that act as new platforms for…”
BackgroundGenetic disorders coupled to ROS deficiency
O’Neill, S., Brault, J., Stasia, M.-J., & Knaus, U. G. (2015) · Redox Biology · doi:10.1016/j.redox.2015.07.009 · Cited by 164
Effects of Ectopic Nanog and Oct4 Overexpression on Mesenchymal Stem Cells
Liu, T. M., Wu, Y. N., Guo, X. M., Hui, J. H. P., Lee, E. H., & Lim, B. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0335 · Cited by 160
Musah, S., Morin, S. A., Wrighton, P. J., Zwick, D. B., Jin, S., & Kiessling, L. L. (2012) · ACS Nano · doi:10.1021/nn3039148 · Cited by 165
TGF-β family signaling in stem cells
Sakaki-Yumoto, M., Katsuno, Y., & Derynck, R. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.008 · Cited by 156
Mechanisms Underlying the Osteo- and Adipo-Differentiation of Human Mesenchymal Stem Cells
Zhang, Y., Khan, D., Delling, J., & Tobiasch, E. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/793823 · Cited by 184
“More recently, a new and interesting source of stem cells has been created by Takahashi and Yamanaka named induced pluripotent stem cells (iPS) [6]. iPS are obtained by genetic reprogramming of differentiated somatic cells of adult tissue using pluripotent factors like Oct4, Sox2, Klf4, and c-myc [7, 8] or Oct4, Sox2,…”
BackgroundCalcium Homeostasis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Lee, Y.-K., Ng, K.-M., Lai, W.-H., Chan, Y.-C., Lau, Y.-M., Lian, Q., Tse, H.-F., & Siu, C.-W. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9273-3 · Cited by 154
“Human induced pluripotent stem cells (hiPSCs) can be generated from adult human dermal fibroblasts by transduction of a defined set of transcription factors to reprogram them back to an equivalent of the early embryonic state [1–4].”
BackgroundOCT4: Dynamic DNA binding pioneers stem cell pluripotency
Jerabek, S., Merino, F., Schöler, H. R., & Cojocaru, V. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.10.001 · Cited by 158
“KLF4 and c-MYC, factorswith a pronounced oncogenic potential, were replaced by NANOG and LIN28 (together with OCT4 and SOX2) and by ESRRB (with OCT4 and SOX2) in the reprogramming cocktail for generating human and mouse iPSCs, respectively [166, 167].”
BackgroundHafner, M., Max, K. E. A., Bandaru, P., Morozov, P., Gerstberger, S., Brown, M., Molina, H., & Tuschl, T. (2013) · RNA · doi:10.1261/rna.036491.112 · Cited by 160
“LIN28 regulates embryonic development, myogenesis, as well as neuronal differentiation, and promotes stem-cell reprogramming (Moss et al. 1997; Polesskaya et al. 2007; Yu et al. 2007; Rybak et al. 2008; Okita et al. 2011).”
BackgroundYao, K., Qiu, S., Tian, L., Snider, W. D., Flannery, J. G., Schaffer, D. V., & Chen, B. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.078 · Cited by 170
Pettinato, G., Lehoux, S., Ramanathan, R., Salem, M. M., He, L.-X., Muse, O., Flaumenhaft, R., Thompson, M. T., Rouse, E. A., Cummings, R. D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45514-3 · Cited by 159
Tzatzalos, E., Abilez, O. J., Shukla, P., & Wu, J. C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.010 · Cited by 162
Oct4 links multiple epigenetic pathways to the pluripotency network
Ding, J., Xu, H., Faiola, F., Ma'ayan, A., & Wang, J. (2012) · Cell Research · doi:10.1038/cr.2011.179 · Cited by 162
“These reprogramming factors, namely Oct4 and Sox2 in combination with Klf4 and c-Myc 6 , or Nanog and Lin28 7 , are also known to be important factors for self-renewal and pluripotency of ESCs.”
Function and Regulation of Let-7 Family microRNAs
Su, J.-L., Chen, P.-S., Johansson, G., & Kuo, M.-L. (2012) · MicroRNA e · doi:10.2174/2211536611201010034 · Cited by 159
Ecdysone Receptors: From the Ashburner Model to Structural Biology
Hill, R. J., Billas, I. M. L., Bonneton, F., Graham, L. D., & Lawrence, M. C. (2013) · Annual Review of Entomology · doi:10.1146/annurev-ento-120811-153610 · Cited by 160
“A topical example of a gene regulatory network operating at a similar level of complexity is the reprogramming of human somatic cells to pluripotent stem cells by the introduction of just four transcription factors (103, 124).”
BackgroundMesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy
Otero-Viñas, M., & Falanga, V. (2016) · Advances in Wound Care · doi:10.1089/wound.2015.0627 · Cited by 171
“In fact, we now know that stem cells can be reprogrammed.(92,93) This classification challenge is very evident with the issue of pluripotency.”
BackgroundHuman-specific genetics: new tools to explore the molecular and cellular basis of human evolution
Pollen, A. A., Kilik, U., Lowe, C. B., & Camp, J. G. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00568-4 · Cited by 153
Ma, N., Liao, B., Zhang, H., Wang, L., Shan, Y., Xue, Y., Huang, K., Chen, S., Zhou, X., Chen, Y., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.496174 · Cited by 158
Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures
Mizuno, H., Spike, B. T., Wahl, G. M., & Levine, A. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017001108 · Cited by 160
“However, the efficiency of the process was very low (6), and the constellation of genes that engender reprogramming is flexible (7).”
BackgroundYe, J.-H., Xu, Y.-J., Gao, J., Yan, S.-G., Zhao, J., Tu, Q., Zhang, J., Duan, X.-J., Sommer, C. A., Mostoslavsky, G., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.053 · Cited by 158
“The generation of iPSCs and the latest development showing the production of iPSCs without intergrating factors [15,45,46], open up new opportunities for the establishment of clinically autologous stem cell lines.”
Present state and future perspectives of using pluripotent stem cells in toxicology research
Wobus, A. M., & Löser, P. (2011) · Archives of Toxicology · doi:10.1007/s00204-010-0641-6 · Cited by 159
A unique Oct4 interface is crucial for reprogramming to pluripotency
Esch, D., Vahokoski, J., Groves, M. R., Pogenberg, V., Cojocaru, V., Bruch, H. V., Han, D., Drexler, H. C. A., Araúzo-Bravo, M. J., Ng, C. K. L., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2680 · Cited by 174
Fang, X., Yoon, J.-G., Li, L., Yu, W., Shao, J., Hua, D., Zheng, S., Hood, L., Goodlett, D. R., Foltz, G., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-11 · Cited by 158
“used to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells [7].”
BackgroundMolecular basis of embryonic stem cell self-renewal: from signaling pathways to pluripotency network
Huang, G., Ye, S., Zhou, X., Liu, D., & Ying, Q.-L. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1833-2 · Cited by 150
Kumano, K., Arai, S., Hosoi, M., Taoka, K., Takayama, N., Otsu, M., Nagae, G., Ueda, K., Nakazaki, K., Kamikubo, Y., et al. (2012) · Blood · doi:10.1182/blood-2011-07-367441 · Cited by 170
Small RNA molecules in the regulation of spermatogenesis
He, Z., Kokkinaki, M., Pant, D., Gallicano, G. I., & Dym, M. (2009) · Reproduction · doi:10.1530/rep-08-0494 · Cited by 176
Good Cell Culture Practice for stem cells and stem-cell-derived models
Pamies, D. (2016) · ALTEX · doi:10.14573/altex.1607121 · Cited by 160
“Multiple methods exist to reprogram somatic cells including Sendai Virus, Retro/Lentivirus, mRNA, piggybac, and Episomal-based approaches (Yu et al., 2007; Shi et al., 2008; Mack et al., 2011; Yu et al., 2009; Woltjen et al., 2009; Stadtfeld et al., 2008).”
MethodScaffolds for 3D in vitro culture of neural lineage cells
Murphy, A. R., Laslett, A., O'Brien, C. M., & Cameron, N. R. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.02.046 · Cited by 159
“Pluripotent stem cells (PSCs) can be expanded indefinitely, can potentially give rise to any cell type in the adult body, and are inclusive of embryonic stem cells (ESCs)[42] and induced pluripotent stem cells (iPSCs)[43, 44].”
BackgroundFligor, C. M., Langer, K. B., Sridhar, A., Ren, Y., Shields, P. K., Edler, M. C., Ohlemacher, S. K., Sluch, V. M., Zack, D. J., Zhang, C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32871-8 · Cited by 161
Cardiomyocyte death and renewal in the normal and diseased heart
Buja, L. M., & Vela, D. C. (2008) · Cardiovascular Pathology · doi:10.1016/j.carpath.2008.02.004 · Cited by 175
Constructing and Deconstructing Stem Cell Models of Neurological Disease
Han, S. S. W., Williams, L. A., & Eggan, K. C. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.003 · Cited by 159
“…in cell aggregates called embryoid bodies (EBs), and in vivo strategies, including the formation of teratomas, which are benign tumors formed after injection of the stem cells into immunodeficient mice (Lowry et al., 2008; Park et al., 2008b; Takahashi et al., 2007; Yu et al., 2007).”
Serum Starvation Induced Cell Cycle Synchronization Facilitates Human Somatic Cells Reprogramming
Chen, M., Huang, J., Yang, X., Liu, B., Zhang, W., Huang, L., Deng, F., Ma, J., Bai, Y., Lu, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028203 · Cited by 182
“somatic cells to return to embryonic stem cells (ESCs) like state [1,2], this synthetic population are termed induced pluripotent stem cells (iPSCs).”
BackgroundImmunogenicity of Pluripotent Stem Cells and Their Derivatives
de Almeida, P. E., Ransohoff, J. D., Nahid, A., & Wu, J. C. (2013) · Circulation Research · doi:10.1161/circresaha.111.249243 · Cited by 159
“When expressed retrovirally, these transcription factors were capable of reprogramming fibroblasts to an embryonic-like state.(20,21) Known as induced pluripotent stem (iPS) cells, they have revolutionized the field of stem cell research by demonstrating somatic cell plasticity and by offering an appealing solution to…”
BackgroundGiuliani, M., Oudrhiri, N., Noman, Z. M., Vernochet, A., Chouaib, S., Azzarone, B., Durrbach, A., & Bennaceur-Griscelli, A. (2011) · Blood · doi:10.1182/blood-2010-12-325324 · Cited by 158
Keung, A. J., Asuri, P., Kumar, S., & Schaffer, D. V. (2012) · Integrative Biology · doi:10.1039/c2ib20083j · Cited by 175
Abilez, O. J., Tzatzalos, E., Yang, H., Zhao, M.-T., Jung, G., Zöllner, A. M., Tiburcy, M., Riegler, J., Matsa, E., Shukla, P., et al. (2018) · Stem Cells · doi:10.1002/stem.2732 · Cited by 153
Qiao, J., Wang, Z., Feng, H.-L., Miao, Y., Wang, Q., Yu, Y., Wei, Y., Yan, J., Wang, W., Shen, W., et al. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.06.001 · Cited by 167
Derive and conquer: sourcing and differentiating stem cells for therapeutic applications
Klimanskaya, I. V., Rosenthal, N. A., & Lanza, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2403 · Cited by 159
“However, recent reports from two groups who successfully reprogrammed human somatic cells with defined transcription factor”
BackgroundGillis, A., Stoop, H., Biermann, K., van Gurp, R. J. H. L. M., Swartzman, E., Cribbes, S., Ferlinz, A., Shannon, M., Oosterhuis, J. W., & Looijenga, L. H. J. (2011) · International Journal of Andrology · doi:10.1111/j.1365-2605.2011.01148.x · Cited by 159
Stem cell therapy for ischemic heart diseases
Yu, H., Lu, K., Zhu, J., & Wang, J. (2017) · British Medical Bulletin · doi:10.1093/bmb/ldw059 · Cited by 159
“In addition, it is reported that iPSCs are similar with ESCs in morphology, proliferation, telomerase activities, feeder dependence, epigenetic status, surface markers, gene expression, formation of embryonic bodies in vitro, promoter activities and teratoma formation in vivo; and the iPS cell culture condition is ide…”
BackgroundHiramatsu, K., Sasagawa, S., Outani, H., Nakagawa, K., Yoshikawa, H., & Tsumaki, N. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44605 · Cited by 165
Human induced pluripotent stem cells and their use in drug discovery for toxicity testing
Scott, C. W., Peters, M. F., & Dragan, Y. P. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.02.020 · Cited by 171
“In contrast to embryonic stem ells, induced pluripotent stem cells (iPSCs) can be derived from ature differentiated cells through the forced expression of paricular pluripotency genes (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundGene-pair expression signatures reveal lineage control
Heinäniemi, M., Nykter, M., Kramer, R., Wienecke-Baldacchino, A., Sinkkonen, L., Zhou, J. X., Kreisberg, R., Kauffman, S. A., Huang, S., & Shmulevich, I. (2013) · Nature Methods · doi:10.1038/nmeth.2445 · Cited by 160
“LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias.”
BackgroundInduced Pluripotent Stem Cells for Regenerative Medicine
Hirschi, K. K., Li, S., & Roy, K. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105108 · Cited by 148
“Cells can be reprogrammed into PiPS cells and then into iPS cells by using transcriptional factor OSKM or OSLN (red arrows).”
MethodZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells
Zhu, P., Wang, Y., He, L., Huang, G., Du, Y., Zhang, G., Yan, X., Xia, P., Ye, B., Wang, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81979 · Cited by 160
“Four TFs (OCT4, SOX2, KLF4, and c-MYC) have been defined as being able to convert differentiated fibroblasts into induced pluripotent stem cells (iPSCs) (9, 10).”
BackgroundTranscription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
Ramlee, M. K., Wang, J., Toh, W. H., & Li, S. (2016) · Genes · doi:10.3390/genes7080050 · Cited by 175
“However, the molecular mechanism underlying hTERT gene activation during induced Pluripotent Stem (iPS) cell reprogramming [31,32] and hTERT gene silencing during cellular differentiation remains largely unclear.”
BackgroundDeficiency of microRNA miR-34a expands cell fate potential in pluripotent stem cells
Choi, Y. J., Lin, C.-P., Risso, D., Chen, S., Kim, T. A., Tan, M. H., Li, J. B., Wu, Y., Chen, C., Xuan, Z., et al. (2017) · Science · doi:10.1126/science.aag1927 · Cited by 158
Revolutionizing medicine: recent developments and future prospects in stem-cell therapy
Hussen, B. M., Taheri, M. N., Yashooa, R. K., Abdullah, G. H., Abdullah, S. R., Kheder, R. K., & Mustafa, S. A. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000002109 · Cited by 185
Lluís, F., Pedone, E., Pepe, S., & Cosma, M. P. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.08.017 · Cited by 168
“Recent findings have shown that overexpression of four specific ESC transcription factors encoding genes in mouse and human somatic cells can induce them to become pluripotent (Aoi et al., 2008; Brambrink et al., 2008; Hanna et al., 2008; Kim et al., 2008; Lowry et al., 2008; Maherali et al., 2007; Park et al., 2008;…”
BackgroundHarb, N., Archer, T. K., & Sato, N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003001 · Cited by 155
“Intriguingly, despite the fundamental differences in the sources of cells and derivation methods, these induced pluripotent stem (iPS) cells emulate not only the differentiation capacities and gene expression patterns seen in ICM-derived ES cells but also the formation of colonies morphologically indistinguishable fro…”
BackgroundAn ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells
Filareto, A., Parker, S., Darabi, R., Borges, L., Iacovino, M., Schaaf, T., Mayerhofer, T., Chamberlain, J. S., Ervasti, J. M., McIvor, R. S., et al. (2013) · Nature Communications · doi:10.1038/ncomms2550 · Cited by 154
“1a, the therapeutic strategy applied in the present study involved (1) reprogramming of dystrophic donor fibroblasts into iPS clones, (2) genetic repair of selected iPS clones with mUTRN using the non-viral Sleeping Beauty Transposon (Tn) System, (3) in vitro differentiation of corrected iPS cell clones into myogenic…”
Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues
Abdulrazzak, H., Moschidou, D., Jones, G. N., & Guillot, P. V. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2010.0347.focus · Cited by 176
Plasticity of Stem Cells Derived from Adult Periodontal Ligament
Huang, C. C., Pelaez, D., Bendala, J. D., Garcı́a-Godoy, F., & Cheung, H. S. (2009) · Regenerative Medicine · doi:10.2217/rme.09.55 · Cited by 156
Characterization of microRNAs Involved in Embryonic Stem Cell States
Stadler, B., Ivanovska, I., Mehta, K., Song, S., Nelson, A., Tan, Y., Mathieu, J., Darby, C., Blau, C. A., Ware, C., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0426 · Cited by 155
“iPS cells were generated from human fi broblasts using either a previously described 4-component cocktail (Oct4, Sox2, Nanog, and Lin28; OSLN) [ 8 ] or 4/3-component cock-tails (Oct4, Sox2, Klf4 with or without c-Myc; OSKM or OSK and M83.”
Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration
Liu, N., Ye, X., Yao, B., Zhao, M., Wu, P., Liu, G., Zhuang, D., Jiang, H., Chen, X., He, Y., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.10.021 · Cited by 147
Induced Pluripotent Stem Cells from Individuals with Recessive Dystrophic Epidermolysis Bullosa
Tolar, J., Xia, L., Riddle, M. J., Lees, C. J., Eide, C. R., McElmurry, R. T., Titeux, M., Osborn, M. J., Lund, T. C., Hovnanian, A., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.346 · Cited by 155
“Patient-specific stem cells, such as the recently identified induced pluripotent stem (iPS) cells (Takahashi and Yamanaka, 2006a; Yu et al., 2007; Park et al., 2008b), present an opportunity to use the progeny of autologous See related commentary on pg 812 ORIGINAL ARTICLE”
BackgroundAmnion Epithelial Cell Isolation and Characterization for Clinical Use
Murphy, S. V., Rosli, S., Acharya, R. Y., Mathias, L., Lim, R., Wallace, E. M., & Jenkin, G. (2010) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc01e06s13 · Cited by 155
MicroRNA Gene Regulatory Pathways in the Establishment and Maintenance of ESC Identity
Martinez, N. J., & Gregory, R. I. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.011 · Cited by 152
HMGA2, MicroRNAs, and Stem Cell Aging
Hammond, S. M., & Sharpless, N. E. (2008) · Cell · doi:10.1016/j.cell.2008.11.026 · Cited by 155
“The Lin-28 protein is highly expressed in ESCs and is also able to promote reprogramming of differentiated somatic cells into pluripotent stem cells (Yu et al., 2007b).”
BackgroundNANOG is a key factor for induction of pluripotency in bovine adult fibroblasts1
Sümer, H., Liu, J., Malaver-Ortega, L. F., Lim, M. L., Khodadadi, K., & Verma, P. J. (2011) · Journal of Animal Science · doi:10.2527/jas.2010-3666 · Cited by 160
“Mouse and human somatic cells can be reprogrammed to a pluripotent state by the ectopic expression of the transcription factors Oct4 and Sox2, in combination with c-Myc and Klf-4 (Takahashi and Yamanaka, 2006) or with NANOG and LIN28 (Yu et al., 2007).”
BackgroundYang, X., Lin, X., Zhong, X., Kaur, S., Li, N., Liang, S., Lassus, H. J., Wang, L., Katsaros, D., Montone, K. T., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2388 · Cited by 171
Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA
Warren, L., Ni, Y., Wang, J., & Guo, X. (2012) · Scientific Reports · doi:10.1038/srep00657 · Cited by 154
Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts
Tsubooka, N., Ichisaka, T., Okita, K., Takahashi, K., Nakagawa, M., & Yamanaka, S. (2009) · Genes to Cells · doi:10.1111/j.1365-2443.2009.01301.x · Cited by 154
“The same factor combination or a partially different combination (OCT3/4, SOX2, NANOG and LIN28) can generate iPS cells from human fibroblasts (Takahashi et al. 2007; Yu et al. 2007).”
BackgroundTrisomy Correction in Down Syndrome Induced Pluripotent Stem Cells
Li, L. B., Chang, K.-H., Wang, P.-R., Hirata, R. K., Papayannopoulou, T., & Russell, D. W. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.08.004 · Cited by 151
“We generated six independent iPSC lines from DS fibroblasts as described (Yu et al., 2007) and validated their trisomy 21 karyotypes (example in Figure S1A available online).”
MethodThe Multiparametric Effects of Hydrodynamic Environments on Stem Cell Culture
Kinney, M. A., Sargent, C. Y., & McDevitt, T. C. (2011) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2011.0040 · Cited by 148
Chang, H.-M., Martinez, N. J., Thornton, J. E., Hagan, J. P., Nguyen, K. D., & Gregory, R. I. (2012) · Nature Communications · doi:10.1038/ncomms1909 · Cited by 149
“Our findings indicate a different mechanism whereby Trim71 functions downstream of Lin28 to sustain ESC self-renewal.”
BackgroundInfluentialMesenchymal Stem Cells from iPS Cells Facilitate Periodontal Regeneration
Hynes, K., Menicanin, D., Han, J., Marino, V., Mrozik, K., Gronthos, S., & Bartold, P. M. (2013) · Journal of Dental Research · doi:10.1177/0022034513498258 · Cited by 150
“The discovery that adult somatic cells can be reprogrammed into a pluripotent stem cell state, through the addition of certain transcription factors (Takahashi et al., 2007; Yu et al., 2007), represents a promising alternative for the generation of large populations of adult-derived stem cells for use in regenerative…”
BackgroundRoles of lncRNA in breast cancer
Watabe, K. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/427 · Cited by 155
Zhao, W., Li, Q., Ayers, S., Gu, Y., Shi, Z., Zhu, Q., Chen, Y., Wang, H. Y., & Wang, R.-F. (2013) · Cell · doi:10.1016/j.cell.2013.02.006 · Cited by 153
“Both human and mouse somatic cells can be reprogrammed to a pluripotent embryonic stem cell (ESC)-like state, giving rise to induced pluripotent stem cells (iPSCs) by the use of four key transcription factors: Oct4, Sox2, Klf4, and c-Myc (Takahashi et al., 2007b; Takahashi and Yamanaka, 2006; Yu et al., 2007).”
Cayo, M. A., Cai, J., DeLaForest, A., Noto, F. K., Nagaoka, M., Clark, B. S., Collery, R. F., Si-Tayeb, K., & Duncan, S. A. (2012) · Hepatology · doi:10.1002/hep.25871 · Cited by 148
Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy
Howden, S. E., Gore, A., Li, Z., Fung, H.-L., Nisler, B. S., Nie, J., Chen, G., McIntosh, B. E., Gulbranson, D. R., Diol, N. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103388108 · Cited by 148
Self-citationHuman-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype
Ivashchenko, C. Y., Pipes, G. C., Lozinskaya, I. M., Lin, Z., Xiaoping, X., Needle, S., Grygielko, E. T., Hu, E., Toomey, J. R., Lepore, J. J., et al. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00819.2012 · Cited by 153
“The creation of human-induced pluripotent stem cells (hiPS) by reprogramming somatic cells with embryonic transcription factors (57, 58, 66, 67) has provided an alternative for in vitro differentiation experiments.”
Qu, Q., Li, D., Louis, K. R., Li, X., Yang, H. B., Sun, Q., Crandall, S. R., Tsang, S., Zhou, J., Cox, C. L., et al. (2014) · Nature Communications · doi:10.1038/ncomms4449 · Cited by 165
Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells
Kaufman, D. S. (2009) · Blood · doi:10.1182/blood-2009-03-191304 · Cited by 166
Sharma, A., Marceau, C., Hamaguchi, R., Burridge, P. W., Rajarajan, K., Churko, J. M., Wu, H., Sallam, K. I., Matsa, E., Sturzu, A. C., et al. (2014) · Circulation Research · doi:10.1161/circresaha.115.303810 · Cited by 148
“Thus, hiPSC-CMs are ideal cells for studying the mechanisms of coxsackievirusinduced viral myocarditis because they are nonimmortalized human cardiomyocytes that express relevant ion channels and sarcomeric proteins found in adult human cardiomyocytes.(19,20) Because there are limited therapeutic options for eliminati…”
BackgroundPluripotent stem cells in neurodegenerative and neurodevelopmental diseases
Marchetto, M. C. N., Winner, B., & Gage, F. H. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq159 · Cited by 152
Physiological Characterisation of Human iPS-Derived Dopaminergic Neurons
Hartfield, E. M., Yamasaki-Mann, M., Ribeiro Fernandes, H. J., Vowles, J., James, W. S., Cowley, S. A., & Wade-Martins, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087388 · Cited by 147
“The generation of human induced pluripotent stem cells (hiPSCs) from somatic cells is enabled by the advent of a range of reprogramming technologies which express pluripotency factors (OCT4, SOX2, KLF4, c-Myc, NANOG and LIN28) [7,8].”
BackgroundRen, Y., Lee, M. Y., Schliffke, S., Paavola, J., Amos, P. J., Ge, X., Ye, M., Zhu, S., Senyei, G., Lum, L., et al. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.04.012 · Cited by 148
“We generated EBs using the fetal lung fibroblasts IMR90 C1 iPS cell line [7].”
MethodSareen, D., Ebert, A. D., Heins, B. M., McGivern, J. V., Ornelas, L., & Svendsen, C. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039113 · Cited by 145
“Reprogramming of the new 77iSMA line was performed using pEP4-E02S-CK2M-EN2L and pEP4-E02S-ET2K vectors (Addgene, according to previously published protocols [28]).”
MethodCD49f Enhances Multipotency and Maintains Stemness Through the Direct Regulation of OCT4 and SOX2
Yu, K., Yang, S., Jung, J., Kim, S., Ko, K., Han, D., Park, S., Choi, S. W., Kang, S., Schöler, H. R., et al. (2012) · Stem Cells · doi:10.1002/stem.1052 · Cited by 171
Biomaterials for Personalized Cell Therapy
Facklam, A. L., Volpatti, L. R., & Anderson, D. G. (2019) · Advanced Materials · doi:10.1002/adma.201902005 · Cited by 158
Generation of induced pluripotent stem cells from bovine embryonic fibroblast cells
Han, X., Han, J., Ding, F., Cao, S., Lim, S. S., Dai, Y., Zhang, R., Zhang, Y.-R., Lim, B., & Li, N. (2011) · Cell Research · doi:10.1038/cr.2011.125 · Cited by 151
A deterministic map of Waddington's epigenetic landscape for cell fate specification
Bhattacharya, S., Zhang, Q., & Andersen, M. E. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-85 · Cited by 172
“Even terminally differentiated adult cells have now been shown to retain considerable phenotypic plasticity and the ability to be reprogrammed into pluripotent stem cell-like states [21-27] or into alternative differentiated lineages [28-34] by forced expression of a single gene or a small number of genes.”
BackgroundEvolving concepts in liver tissue modeling and implications for in vitro toxicology
Guillouzo, A., & Guguen-Guillouzo, C. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.10.1279 · Cited by 145
“Another team has come to the same result with OCT4, SOX2, NANOG and LIN28, although LIN28 was not strictly required [141] .”
ResultPathological Ventricular Remodeling: Therapies: Part 2 of 2
Xie, M., Burchfield, J. S., & Hill, J. A. (2013) · Circulation · doi:10.1161/circulationaha.113.001879 · Cited by 171
“Scientists have successfully reprogrammed adult fibroblasts to dedifferentiate into a ES cell–like state.(93,94) These cells, called induced pluripotent stem (iPS) cells, are viewed as a major scientific breakthrough in the field of regenerative medicine.”
BackgroundmicroRNAs: important regulators of stem cells
Li, N., Long, B., Han, W., Yuan, S., & Wang, K. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0551-0 · Cited by 162
“Human iPSCs are generated by transduction of the alternative combinations of Oct3/4, Sox2, Nanog, and Lin28 [22].”
BackgroundDenton, K. R., Lei, L., Grenier, J. M., Rodionov, V., Blackstone, C. D., & Li, X.-J. (2014) · Stem Cells · doi:10.1002/stem.1569 · Cited by 162
Cardiogenic Differentiation and Transdifferentiation of Progenitor Cells
Reinecke, H., Minami, E., Zhu, W., & Laflamme, M. A. (2008) · Circulation Research · doi:10.1161/circresaha.108.180588 · Cited by 161
Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility
Wissing, S., Muñoz-Lopez, M., Macia, A., Yang, Z., Montano, M., Collins, W., Garcia-Perez, J. L., Moran, J. V., & Greene, W. C. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr455 · Cited by 146
“While iPSCs might one day be of great value in the treatment of currently incurable human diseases (2,3), several challenges posed by these cells must be overcome.”
BackgroundHMGA regulates the global chromatin state and neurogenic potential in neocortical precursor cells
Kishi, Y., Fujii, Y., Hirabayashi, Y., & Gotoh, Y. (2012) · Nature Neuroscience · doi:10.1038/nn.3165 · Cited by 159
Chen, J., Liu, J., Yang, J., Chen, Y., Chen, J., Ni, S., Song, H., Zeng, L., Ding, K., & Pei, D. (2011) · Cell Research · doi:10.1038/cr.2010.172 · Cited by 124
Investigational Therapies for Ischemic Stroke: Neuroprotection and Neurorecovery
Sahota, P., & Savitz, S. I. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0040-6 · Cited by 164
“Recent developments in the induction of pluripotent stem cells from somatic adult cells provide a tremendous opportunity for this field [143–145] to consider an alternative source of pluroipotent cells rather than ESCs.”
BackgroundGenome maintenance in pluripotent stem cells
Weissbein, U., Benvenisty, N., & Ben-David, U. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201310135 · Cited by 147
Nakanishi, M., & Otsu, M. (2012) · Current Gene Therapy · doi:10.2174/156652312802762518 · Cited by 147
“Reprogramming skin fibroblasts into induced pluripotent stem cells (iPSCs) by the ectopic expression of four reprogramming factors (Oct4, Sox2, Klf4 and c-Myc) opened a new era in this field [48-51].”
BackgroundDefining the nature of human pluripotent stem cell progeny
Patterson, M., Chan, D. N., Ha, I., Case, D., Cui, Y., Handel, B. V., Mikkola, H. K., & Lowry, W. E. (2012) · Cell Research · doi:10.1038/cr.2011.133 · Cited by 145
Metadata
- Authors
- Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., & Thomson, J. A.
- Affiliations
- WiCell (US)
- Genome Center of Wisconsin, Madison, WI 53706–1580, USA.
- Venue
- Science
- Published
- 2007-12-21
- Volume
- 318
- Issue
- 5858
- Pages
- 1917-1920
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2142046859
- Cited by
- 10,310
- References
- 14
- Citations by year
- 2026: 167 · 2025: 219 · 2024: 285 · 2023: 322 · 2022: 332 · 2021: 506 · 2020: 441 · 2019: 443 · 2018: 452 · 2017: 515 · 2016: 580 · 2015: 652 · 2014: 692 · 2013: 816 · 2012: 940
- FWCI
- 271.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (P20GM069981)
- National Center for Research Resources (P51RR000167)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, somatic cell nuclear transfer, reprogramming factors, Oct4, SOX2, Nanog, Lin28, pluripotency, telomerase activity, germ layer differentiation, karyotype, disease models, drug development, transplantation medicine
- MeSH terms
- Nanog Homeobox Protein, Animals, Cell Differentiation, Cell Line, DNA-Binding Proteins, Fetus, Fibroblasts, Humans, Infant, Newborn, Karyotyping, Teratoma, Transcription Factors, Transduction, Genetic, Mice, SCID, RNA-Binding Proteins, Homeodomain Proteins, Transgenes, Oligonucleotide Array Sequence Analysis, HMGB Proteins, Stem Cell Transplantation, Pluripotent Stem Cells, Cell Shape, Cell Proliferation, Octamer Transcription Factor-3, Mice, Embryonic Stem Cells, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.